ARDT — Ardent Health Partners, LLC

Summary of Ardent Health's Q4 2025 Earnings Call

1. Key Financial Results and Metrics

• Q4 Revenue: $1.61 billion, flat year-over-year; adjusted for prior year benefits, growth would be approximately 3%.
• Full Year Revenue: $6.3 billion, a 6% increase, within guidance range.
• Adjusted EBITDA: $134 million for Q4, 2% above guidance; full year adjusted EBITDA grew 9% to $545 million with a margin expansion of 20 basis points to 8.6%.
• Operating Cash Flow: $223 million in Q4 and $471 million for the full year, up 49% from 2024.
• Balance Sheet: Cash increased by $150 million to over $700 million; lease adjusted net leverage improved to 2.5x from 2.9x.

2. Strategic Updates and Business Highlights

• IMPACT Program: Progressing well, with expected annualized savings raised to $55 million, up from $40 million. Initiatives focused on cost optimization and performance improvement.
• Operational Efficiency: Salaried wages and benefits decreased by 0.4% year-over-year in Q4; contract labor expenses reduced by 26%.
• Technology Investments: Expansion of AI-assisted virtual care and other technologies aimed at improving operational efficiency and patient care.
• Outpatient Strategy: Continued growth in urgent care and ambulatory services, with plans for new facilities and services.

3. Forward Guidance and Outlook

• 2026 Revenue Guidance: Expected between $6.4 billion and $6.7 billion, reflecting a growth of approximately 3.6% at the midpoint.
• Adjusted EBITDA Guidance: Projected at $485 million to $535 million, considering headwinds from payer denials and professional fees.
• Expectations for 2026: Anticipated continued growth in admissions and improved operational performance, with a return to adjusted EBITDA growth expected in 2027.

4. Bad News, Challenges, or Points of Concern

• Payer Denials and Professional Fees: Continued pressure with no significant improvement expected; professional fees grew by 8% in Q4, down from 11% in Q3.
• Exchange Disruption: Anticipated enrollment declines due to the expiration of enhanced subsidies, with a projected 20% decline in enrollment and potential shifts to self-pay.
• Volume Impact from Weather: Minor impacts from winter storms in Texas and Oklahoma, but not expected to have a lasting effect.

5. Notable Q&A Insights

• Professional Fees: Expected to remain high single-digit growth for 2026, with no significant reductions anticipated.
• HIX Enrollment Dynamics: Anticipated 20% decline in enrollment, with a shift of 10-15% to employer-sponsored coverage.
• IMPACT Program Savings: Majority of the $15 million increase in savings identified in salaries, wages, and benefits.
• Technology Initiatives: AI and virtual care expected to enhance efficiency and patient care, with ongoing investments in these areas.

Overall, Ardent Health reported a strong finish to 2025, with solid financial performance and strategic initiatives in place to address industry challenges. However, headwinds from payer denials and enrollment declines pose risks for 2026.